There are also findings that demonstrated the downregulation of FTO playing an oncogenic role in intrahepatic cholangiocarcinoma and clear cell renal cell carcinoma, respectively [31, 32]. This evidence concerns the gene FTO and intrahepatic cholangiocarcinoma.